Patents by Inventor CHUN-HSU PAN

CHUN-HSU PAN has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Patent number: 11066378
    Abstract: The present invention develops a series of methyl caffeate derivatives having biological activity in anti-angiogenesis. The present invention suggests that the compounds of the invention possess inhibiting angiogenesis through regulation of VEGF/VEGFR-2 and its downstream signaling cascades in the vascular endothelial cells (VECs).
    Type: Grant
    Filed: June 4, 2015
    Date of Patent: July 20, 2021
    Assignees: Taipei Medical University, China Medical University
    Inventors: Chieh-Hsi Wu, Yueh-Hsiung Kuo, Chun-Hsu Pan
  • Patent number: 10238701
    Abstract: The invention provides a water extract of Yan-Sheng-Yin (YSY), a Chinese natural dietary supplement for treatment and/or prevention of hyperlipidemia, atherogenesis and obesity, comprised entirely of natural foods and a preparation comprising the same.
    Type: Grant
    Filed: October 14, 2016
    Date of Patent: March 26, 2019
    Assignee: Taipei Medical University
    Inventors: Chieh-Hsi Wu, Chun-Hsu Pan, Chi-Han Wu
  • Publication number: 20180104291
    Abstract: The invention provides a water extract of Yan-Sheng-Yin (YSY), a Chinese natural dietary supplement for health promotion, comprised entirely of natural foods and a preparation comprising the same. The invention also provides a method for treatment and/or prevention of hyperlipidemia, atherogenesis and obesity.
    Type: Application
    Filed: October 14, 2016
    Publication date: April 19, 2018
    Inventors: Chieh-Hsi Wu, Chun-Hsu Pan, Chi-Han Wu
  • Publication number: 20160355493
    Abstract: The present invention develops a series of methyl caffeate derivatives having biological activity in anti-angiogenesis. The present invention suggests that the compounds of the invention possess inhibiting angiogenesis through regulation of VEGF/VEGFR-2 and its downstream signaling cascades in the vascular endothelial cells (VECs).
    Type: Application
    Filed: June 4, 2015
    Publication date: December 8, 2016
    Inventors: Chieh-Hsi Wu, Yueh-Hsiung Kuo, Chun-Hsu Pan
  • Patent number: 9238620
    Abstract: The invention relates to uses of the sulfur-containing compound in inhibiting activities of a factor related to cancer metastasis and/or growth. Preferably, the invention relates to uses of the sulfur-containing compound in inhibiting lung cancer metastasis and/or growth.
    Type: Grant
    Filed: July 9, 2014
    Date of Patent: January 19, 2016
    Assignee: NATIONAL SUN YAT-SEN UNIVERSITY
    Inventors: Chieh-Hsi Wu, Jyh-Horng Sheu, Chih-Yi Chen, Yi-Chung Chien, Shuo-Chueh Chen, Chun-Hsu Pan, Chiung-Yao Huang
  • Publication number: 20160009642
    Abstract: The invention relates to uses of the sulfur-containing compound in inhibiting activities of a factor related to cancer metastasis and/or growth. Preferably, the invention relates to uses of the sulfur-containing compound in inhibiting lung cancer metastasis and/or growth.
    Type: Application
    Filed: July 9, 2014
    Publication date: January 14, 2016
    Inventors: CHIEH-HSI WU, JYH-HORNG SHEU, CHIH-YI CHEN, YI-CHUNG CHIEN, SHUO-CHUEH CHEN, CHUN-HSU PAN, CHIUNG-YAO HUANG